Ensuring Access to Essential Drugs Act

Bill 119 HR 1922, also known as the "Medicare Part D Manufacturer Discount Exemption Act," aims to make changes to the Medicare program under Title XVIII of the Social Security Act. Specifically, this bill seeks to exempt certain drugs from the Part D manufacturer discount program.

The Part D manufacturer discount program was established to provide discounts on prescription drugs to Medicare beneficiaries. However, some drugs are currently required to participate in this program, which can limit access to certain medications for patients.

If passed, Bill 119 HR 1922 would allow certain drugs to be exempt from the Part D manufacturer discount program. This exemption would provide more flexibility for manufacturers and potentially increase access to a wider range of medications for Medicare beneficiaries. Overall, this bill addresses concerns about access to prescription drugs for Medicare beneficiaries and aims to improve the efficiency and effectiveness of the Medicare program. It will be important to monitor the progress of this bill as it moves through the legislative process to see how it may impact Medicare beneficiaries and the healthcare system as a whole.